Translating sarcoma antigen-directed co-stimulatory NK cells to the clinic |
Baylor College of Medicine / Robin Parihar, MD/PhD |
Reach Grants |
2024 |
Texas |
Translating sarcoma antigen-directed co-stimulatory NK cells to the clinic |
Baylor College of Medicine / Robin Parihar |
Reach Grants |
2024 |
Texas |
IGFBPL1 Peptide-Centric Chimeric Antigen Receptor Autologous T Cells for Relapsed HLA-A*02 Neuroblastoma and Medulloblastoma |
Children’s Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2024 |
Pennsylvania |
Systematic screening of receptor pairs combinations for improving solid tumor cancer immunotherapy |
Baylor College of Medicine / Xavier Rios, MD/PhD |
'A' Award Grants |
2024 |
Texas |
Targeting Novel Inflammatory Signaling Pathways in Juvenile Myelomonocytic Leukemia |
Indiana University / Santhosh Kumar Pasupuleti, PhD |
'A' Award Grants |
2024 |
Indiana |
Gene-mediated cytotoxic immunotherapy in pediatric patients with recurrent malignant brain tumors |
University of Michigan / Andrea Franson, MD |
'A' Award Grants |
2024 |
Michigan |
The role of reactive gliosis in response to Immunotherapy in Diffuse Midline Glioma |
University of Florida / Christina von Roemeling, PhD |
Innovation Grants |
2024 |
Florida |
Targeting and imaging immunometabolic vulnerabilities in diffuse midline glioma |
The Regents of the University of California San Francisco / Pavithra Viswanath, PhD |
Innovation Grants |
2024 |
California |
Development of CAR-T therapy for Ewing sarcoma using zebrafish in vivo models |
Children’s Hospital Los Angeles / James Amatruda, MD/PhD |
Innovation Grants |
2024 |
California |
Development of CAR-T therapy for Ewing sarcoma using zebrafish in vivo models |
Children’s Hospital Los Angeles / James Amatruda, MD/PhD |
Innovation Grants |
2024 |
California |